| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.7M | — | +3.6% |
| Cost of Revenue | $3.4M | — | -2.4% |
| R&D Expense | $3.1M | — | +32.4% |
| SG&A Expense | $8.0M | — | -11.3% |
| Operating Income | -$7.9M | — | +6.7% |
| Pre-tax Income | -$8.3M | — | -167.9% |
| Income Tax | $10K | — | +42.9% |
| Net Income | -$8.3M | — | -167.7% |
| EPS (Basic) | -$0.76 | — | +33.9% |
| EPS (Diluted) | -$0.76 | — | +33.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.4M | +14.5% | -5.5% |
| Accounts Receivable | $4.1M | -20.5% | +23.2% |
| Inventory | $7.7M | -1.8% | -32.7% |
| Current Assets | $39.0M | -14.1% | -13.3% |
| Total Assets | $64.8M | -11.9% | -17.4% |
| Current Liabilities | $21.2M | -7.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.7M | — | -106.8% |
| Investing Cash Flow | $5.5M | — | +138.8% |
| Financing Cash Flow | $657K | — | -94.0% |
| -19.6% |
| Total Liabilities | $27.3M | -6.2% | -9.5% |
| Stockholders' Equity | $37.5M | -15.7% | -22.3% |